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Abstract
Background: The world-wide increase of foodborne infections with antibiotic resistant pathogens
is of growing concern and is designated by the World Health Organization as an emerging public
health problem. Thermophilic Campylobacter have been recognised as a major cause of foodborne
bacterial gastrointestinal human infections in Switzerland and in many other countries throughout
the world. Poultry meat is the most common source for foodborne cases caused by Campylobacter.
Because all classes of antibiotics recommended for treatment of human campylobacteriosis are also
used in veterinary medicine, in view of food safety, the resistance status of Campylobacter isolated
from poultry meat is of special interest.
Methods: Raw poultry meat samples were collected throughout Switzerland and Liechtenstein at
retail level and examined for Campylobacter spp. One strain from each Campylobacter-positive
sample was selected for susceptibility testing with the disc diffusion and the E-test method. Risk
factors associated with resistance to the tested antibiotics were analysed by multiple logistic
regression.
Results: In total, 91 Campylobacter spp. strains were isolated from 415 raw poultry meat samples.
Fifty-one strains (59%) were sensitive to all tested antibiotics. Nineteen strains (22%) were
resistant to a single, nine strains to two antibiotics, and eight strains showed at least three antibiotic
resistances. Resistance was observed most frequently to ciprofloxacin (28.7%), tetracycline
(12.6%), sulphonamide (11.8%), and ampicillin (10.3%). One multiple resistant strain exhibited
resistance to five antibiotics including ciprofloxacin, tetracycline, and erythromycin. These are the
most important antibiotics for treatment of human campylobacteriosis. A significant risk factor
associated with multiple resistance in Campylobacter was foreign meat production compared to
Swiss meat production (odds ratio = 5.7).
Conclusion:  Compared to the situation in other countries, the data of this study show a
favourable resistance situation for Campylobacter strains isolated from raw poultry meat produced
in Switzerland. Nevertheless, the prevalence of 19% ciprofloxacin resistant strains is of concern and
has to be monitored. "Foreign production vs. Swiss production" was a significant risk factor for
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multiple resistance in the logistic regression model. Therefore, an adequate resistance-monitoring
programme should include meat produced in Switzerland as well as imported meat samples.
Background
The importance of Campylobacter jejuni and Campylobacter
coli as foodborne pathogens has steadily increased during
the last years. With an incidence of 92 reported cases per
100'000 inhabitants, Campylobacter spp. are the leading
cause of bacterial zoonosis in Switzerland [1]. Inade-
quately cooked meat, particularly poultry, unpasteurised
milk and contaminated drinking water are the most com-
mon sources for epidemic and sporadic foodborne cases
[2,3]. Due to the often self-limiting diarrhoea in humans,
antibiotic treatment is normally not required. Neverthe-
less, antibiotic treatment is indicated for severe and pro-
longed enteritis, septicaemia, and for persons at risk such
as very young or immuno-compromised patients. Besides
erythromycin, which is the antibiotic of choice, fluoroqui-
nolones and tetracycline are commonly used [4]. Particu-
larly fluoroquinolones are first-line drugs for empiric
therapy of acute diarrhoea, as they are effective against
most major pathogens causing bacterial enteritis [5,6].
Therefore, most cases of campylobacteriosis receiving
antibiotic treatment will initially be treated with fluoro-
quinolones. Worrying is the fact, that in recent years a rap-
idly increasing proportion of Campylobacter isolates from
humans and animals all over the world were found to be
resistant to fluoroquinolones [7-11]. This coincided with
initiation of the use of the fluoroquinolones to food ani-
mals in many countries [12-15].
The objectives of this study were i) to determine the prev-
alence of antibiotic resistant Campylobacter strains in raw
poultry meat samples at retail level, and ii) to identify pos-
sible risk factors associated.
Methods
For sampling, 122 retail stores throughout Switzerland
and Liechtenstein were randomly selected. From March
until July 2002, food safety inspectors of the cantonal lab-
oratories collected 415 samples of raw poultry meat
(whole chickens as well as parts such as cutlet, meat cut
into strips, legs, drumsticks, wings, and breast) from
selected stores. Additionally, information about housing
type of the poultry (as labelled), the country of origin (as
labelled), refrigeration (chilled, frozen), and packing of
the samples was recorded.
Of each sample, 10 g was inoculated into 100 ml selective
enrichment broth (Brucella broth (211088, Becton Dick-
inson, Sparks, USA) with Campylobacter growth and selec-
tive supplement (SR084E, SR069E, Oxoid, Basingstoke,
Hampshire, UK)) and incubated at 42°C for 24 h under
microaerobic conditions provided by commercial gas
packs (CampyGen from Oxoid). After enrichment the
samples were streaked on selective agar media (Brucella
agar (211086 Becton Dickinson) with 6% horse blood
(SR0048C, Oxoid)) as well as Butzler Campylobacter selec-
tive supplement (SR085E, Oxoid) and incubated at 42°C
for another 24 h under microaerobic conditions. Translu-
cent white, moist and glistening colonies were picked and
taken for further identification. Identification of Campylo-
bacter strains was performed using the following standard
tests: gram-negative stain, characteristic motion, catalase-
and oxidase reactions, aerobic growth. One strain from
each Campylobacter-positive sample was selected for sus-
ceptibility testing.
The disc diffusion method was performed as recom-
mended by the National Committee for Clinical Labora-
tory Standards [16]. The following antibiotic impregnated
discs (bioMérieux SA, France) were used: erythromycin
(15 µg), ciprofloxacin (5 µg), tetracycline (30 µg), gen-
tamicin (10 µg), streptomycin (10 µg), ampicillin (10 µg),
amoxicillin (25 µg) and sulphonamide (20 µg). Three to
five isolated colonies of the same morphological type
were selected from the agar plate culture and transferred
into trypticase soy broth (211768, Becton Dickinson).
After incubation at 42°C for 24 h under microaerobic
conditions a sterile cotton swab was dipped into the sus-
pension and streaked on the entire surface of a Mueller-
Hinton agar (CM 337, Oxoid) with 5% sheep blood. Four
antibiotic discs were placed on each plate and after 48 h
of microaerobic incubation at 42°C the diameter of the
inhibition zone was measured with calipers. E. coli ATCC
25922 and S. aureus ATCC 25923 were used as reference
strains. Zones of growth inhibition were evaluated accord-
ing to the NCCLS standards.
The E-test (AB Biodisk, Solna, Sweden) was performed for
erythromycin, ciprofloxacin and tetracycline on Mueller-
Hinton agar supplemented with 5% sheep blood accord-
ing to the manufacture's instructions. Inocula were pre-
pared by incubating the strains for 24 h at 42°C under
microaerobic conditions in trypticase soy broth. After
application of the E-test strips, plates were incubated in
microaerobic conditions at 42°C for 48 h. The minimal
inhibition concentration (MIC) was read directly from the
test strip at the point where the elliptical zone of inhibi-
tion intersected the MIC scale on the strip. The following
NCCLS zone diameter (mm) and MIC breakpoints for
resistance were applied: erythromycin ≤ 13 mm and MIC
≥ 8 mg/l, ciprofloxacin ≤ 15 mm and MIC ≥ 4 mg/l,BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/39
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tetracycline ≤ 14 mm and MIC ≥ 16 mg/l, streptomycin ≤
11 mm, ampicillin ≤ 13 mm, gentamicin ≤ 12 mm, amox-
icillin ≤ 13 mm and sulphonamide ≤ 12 mm.
Statistical analysis consisted of initial bivariate screening
for possible risk factors associated with resistance to the
tested antibiotics. Variables screened for were:
• production system: free range production or production
with bedding and winter garden, labelled as 'animal
friendly' vs. conventional production
• foreign production vs. Swiss production
• whole chicken vs. parts of chicken
• products sold pre-packed vs. products sold in open
displays
• chilled products vs. frozen products
A χ2 test was applied to determine significance in bivariate
screening. Factors significantly associated with antibiotic
resistance (p < 0.05) were included into a multiple logistic
regression model. Variable selection was performed by
stepwise backward selection. Only significant variables (p
< 0.05) were retained in the model. For each tested antibi-
otic, a separate regression analysis was performed. In
addition, risk factors for multiple resistance, defined as
resistance to at least two of the tested antibiotics, were
determined in a separate regression model. All statistical
analyses were performed with the statistical software
package NCSS 2000 (Number Cruncher Statistical Sys-
tems, Kaysville, Utah, USA).
Results
Samples
Overall, 415 samples of raw poultry meat products were
purchased from 122 retail shops and cultured for Campy-
lobacter spp. Information about housing type of poultry,
processing, packing, refrigeration, and the country of ori-
gin of the sampled poultry products is given in table 1.
Campylobacter prevalence
Ninety-one out of 415 (21.9%) raw poultry meat samples
were found to be positive for Campylobacter spp. As the
meat samples were purchased only between March and
July, no seasonal trend for prevalence of positive samples
could be observed. There was no statistically significant
difference between housing types. The prevalence of
Campylobacter positive samples was 20.4% for conven-
tionally produced poultry, and 24% for 'animal-friendly'
produced poultry. Furthermore, no statistically significant
difference was found for the origin of the meat (21% for
imported products and 22.3% for Swiss products), the
product categories (21.3% for samples from whole
chicken and 22.4% for samples from parts of chicken),
and the package (21.4% for pre-packed products and
23.4% for products sold in open displays). Frozen
products had a statistically significant lower prevalence of
Campylobacter positive samples than chilled products
Table 1: Poultry meat products, purchased from retail. Description of sampled poultry meat products (n = 415), purchased from 122 
retail shops.
Raw poultry meat samples (n = 415)
Product category Sample size %
Conventional production 240 58%
'Animal-friendly' production 175 42%
Samples from whole chickens 178 43%
Samples from parts of chicken 237 57%
Poultry sold pre-packed 308 74%
Poultry sold in open displays 107 26%
Frozen poultry 76 18%
Chilled poultry 339 82%
Swiss production 296 71%
Imported products 119 29%
Country of origin: France 46
Hungary 20
Italy 19
Germany 17
Denmark 13
Other countries 4BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/39
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(7.9% and 25.1%, respectively; OR = 4.3; 95%CI 1.8–
10.3).
Susceptibility testing
In total, 87 Campylobacter strains were isolated for suscep-
tibility testing. Fifty-one strains (58.6%) were sensitive to
all tested antibiotics, 36 strains (41.4%) were resistant to
at least one of the antibiotics. Nineteen strains (21.8%)
were resistant to a single and nine strains to two antibiot-
ics. Triple resistance was shown four times. Two strains
were observed with fourfold and fivefold resistance,
respectively. The resistance pattern of a fivefold resistant
strain showed a striking combination of ciprofloxacin, tet-
racycline and erythromycin, the most important antibiot-
ics for treatment of human campylobacteriosis. Overall,
in multiple resistant isolates, patterns of resistance were
heterogeneous.
In figure 1 the results of the sampled retail shops are
shown with a possible classification.
Using the disc diffusion method, nine (10.3%) out of 87
strains were resistant to ampicillin, twenty-five (28.7%) to
ciprofloxacin, one to erythromycin (1.1%), eleven
(12.6%) to tetracycline, seven (8.0%) to streptomycin and
none to gentamicin. Five strains (5.9%) out of 85 tested
were resistant to amoxicillin and nine (11.8%) out of 76
tested resistant to sulphonamide.
The results of susceptibility testing using the E-test
method are shown in figure 2. The comparison of the
results for ciprofloxacin and erythromycin showed no
differences between the disc diffusion and the E-test
method, whereas for tetracycline, there was one strain
Distribution and classification of retail shops Figure 1
Distribution and classification of retail shops. Distribution and classification of the 122 retail shops included in this study. 
Green dots: shops without Campylobacter-positive samples. Yellow dots: shops with at least one Campylobacter-positive sample; 
no antibiotic resistance. Orange dots: shops with at least one sample with Campylobacter resistant to one of the tested antibi-
otics. Red dots: shops with at least one sample with Campylobacter resistant to more than one antibiotic.BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/39
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Results of E-test method Figure 2
Results of E-test method. Results of susceptibility testing to ciprofloxacin, erythromycin and tetracycline using the E-test 
method. Susceptible strains are marked in blue. Strains with a minimal inhibition concentration (MIC) higher than the break-
point value for resistance are marked in red.
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marginally classified as resistant using the disc diffusion
method but susceptible using the E-test method.
Risk factor analysis
Figure 3 provides an overview of antibiotic resistance in
isolates from 'animal-friendly' and conventional produc-
tion, and from Swiss and foreign products, respectively. In
bivariate analysis "conventional production system vs.
'animal-friendly' production system" (OR = 5.2; 95%CI
1.4–19.8) was one of two significant risk factors for resist-
ance to at least two antibiotics. The second factor, "foreign
production vs. Swiss production", was the only risk factor
remaining significant for multiple resistance in the logistic
regression model (OR = 5.7; 95%CI 1.8–17.7). Risk fac-
tors for resistance to ampicillin, amoxicillin, cipro-
floxacin, and tetracycline are shown in table 2. No
significant risk factors could be identified for resistance in
Campylobacter strains to erythromycin, streptomycin and
sulphonamide.
Discussion
The high prevalence of Campylobacter spp. in raw poultry
meat samples found in this study agrees with data from
other studies [17-19]. Compared to the situation in other
countries, the data of this study show a favourable resist-
ance situation for Campylobacter strains isolated from raw
poultry meat produced in Switzerland. In the USA, 90% of
Campylobacter  strains isolated from poultry meat had
resistance to at least one and 45% to at least two antibiot-
ics [20].
In our study, 28.7% of the isolated strains were resistant
to ciprofloxacin. This prevalence is comparable to the
results reported in the cited American study [20]. A much
higher prevalence of ciprofloxacin resistant strains was
found in Austria (47%) [21], while a lower prevalence was
reported in Denmark (6%) [22]. However, it has to be
considered, that in our study the resistance to cipro-
floxacin was significantly higher in Campylobacter spp. iso-
lated from foreign products than from Swiss products.
Nevertheless, the prevalence of ciprofloxacin resistance in
Campylobacter strains from Swiss poultry meat products
was 19% and thus higher than for any other antibiotic
tested. Data on resistance patterns of Campylobacter iso-
lated from humans in Switzerland only have limited
validity (small number of non-representative samples).
Nevertheless, the highest rates for resistance, in the last
four years, were observed for nalidixid acid (over 80% of
isolates) [23]. As there is strong cross resistance to fluoro-
quinolones which are most frequently used for empiric
antimicrobial treatment of acute diarrhoea, this fact gives
cause for concern. In Switzerland Baytril®(enrofloxacin) is
licensed for therapeutic use in poultry and therefore,
ongoing monitoring is required. Twelve point six percent
of the isolated strains in our study were resistant against
tetracycline. A much higher prevalence of tetracycline
resistant strains was found in USA (66%), and in Austria
(47%) [20,21]. Only 7% of the strains in the Danish study
were tetracycline resistant [22].
Comparable to our data, a low resistance prevalence
against erythromycin was also reported in Austria and
Denmark [21,22], whereas in the USA 20% erythromycin
resistant strains were found [20].
In a recent Swiss study resistance patterns of Campylobacter
strains isolated from finishing pigs were investigated [24].
Whereas prevalence of resistance against ciprofloxacin,
tetracycline, and gentamicin in these strains was similar to
the results of this study, prevalence of resistance against
erythromycin and streptomycin was 19.8% and 79.1%,
respectively, and therefore much higher than in strains
isolated from poultry meat. This finding is consistent with
Danish data [25] finding a higher prevalence of resistance
to streptomycin in Campylobacter coli, predominantly
isolated in pigs, than in Campylobacter jejuni, the predom-
inantly strain in poultry meat. Generally, the comparison
of different studies turned out to be difficult because of
different sample collection and varieties in culture meth-
ods and susceptibility test methods.
A noteworthy finding was the apparent clustering of retail
shops with at least one sample with Campylobacter resist-
ant to multiple antibiotics in the south of Switzerland
(figure 1). This could be explained by the high proportion
of imported poultry meat products in this region. How-
Table 2: Risk factors for antibiotic resistance. Significant risk factors (p < 0.05) for Campylobacter resistance to ciprofloxacin, 
tetracycline, ampicillin, and amoxicillin, ascertained by logistic regression models.
Antibiotic Variable Odds Ratio 95 %-confidence interval P
Ciprofloxacin foreign vs. Swiss production 5.0 1.8 – 13.9 0.001
Tetracycline foreign vs. Swiss production 10.0 2.4 – 42.1 0.002
Ampicillin foreign vs. Swiss production 6.7 1.5 – 29.4 0.01
Amoxicillin sale in open displays vs. pre-packed 11.2 1.2 – 106.3 0.03BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/39
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Resistance according to production system and to origin Figure 3
Resistance according to production system and to origin. Comparison of antibiotic resistance in Campylobacter spp. 
isolated from conventional (n = 50) and, animal-friendly' (n = 37) products and from foreign (n = 24) and Swiss (n = 63) prod-
ucts, respectively.
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ever, due to sample size limitations, analysis by country of
origin did not produce meaningful results. Moreover, the
results of this study indicate an association between
Campylobacter  spp. being resistant to amoxicillin and
poultry products sold in open displays. One could specu-
late that this astonishing result may be based on a
different origin of the products. Samples from products
sold in open displays were predominantly from small
local butcheries. Pre-packed products, on the other hand,
were primarily sampled in supermarkets. However, no
data are available on the patterns of antibiotics use in
poultry farms delivering to small butcheries or to
supermarkets.
It is known that poultry from free range housing systems
have a higher risk of being infected with Campylobacter
spp. than poultry from conventional housing systems
[26]. However, there was no significant association
between these systems and the occurrence of antibiotic
resistance in the isolated strains. While in bivariate analy-
sis, both "conventional production vs. 'animal-friendly'
production" and "foreign production vs. Swiss
production" were significant risk factors for multiple
resistance, only "foreign production vs. Swiss production"
remained significant in the logistic regression model. This
means that the univariate results were caused by con-
founding as the majority of 'animal-friendly' samples was
produced in Switzerland.
Conclusions
In this study, the overall prevalence of ciprofloxacin resist-
ance in Campylobacter strains from raw poultry meat
(29%) was higher than the prevalence of ciprofloxacin
resistance in Campylobacter strains from poultry meat
produced in Switzerland (19%) and foreign versus Swiss
production was a significant risk factor for multiple resist-
ant strains in the logistic regression model. Therefore, a
national monitoring program for antibiotic resistance
needs to include both domestically produced and
imported meat.
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